Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C5orf34 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | CEP170B | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | MPP2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | TSPYL2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | PRELID3A | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TOX | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | LINC00684 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | FYTTD1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | KIFC1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |